US Patent Issued to SpecNova on July 7 for "Liposomal compositions and methods of use thereof for improved stability, bioavailability and sustained release" (Colorado Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,026, issued on July 7, was assigned to SpecNova LLC (Tysons Center, Va.).

"Liposomal compositions and methods of use thereof for improved stability, bioavailability and sustained release" was invented by Sebastian Balcombe (Evergreen, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The embodiments disclosed herein relate to a liposomal composition for sustained release of an active ingredient. In various implementations, the liposomal composition may have a first liposomal core of Phosphatidylcholine (PC), phosphatidylethanolamine (PE), or phosphatidylserine (PS) and the active ingredient dispersed within the first liposomal core. A second core ...